219 related articles for article (PubMed ID: 10926790)
1. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN.
Bell MC; Crowley-Nowick P; Bradlow HL; Sepkovic DW; Schmidt-Grimminger D; Howell P; Mayeaux EJ; Tucker A; Turbat-Herrera EA; Mathis JM
Gynecol Oncol; 2000 Aug; 78(2):123-9. PubMed ID: 10926790
[TBL] [Abstract][Full Text] [Related]
2. Chapter 17: Genital human papillomavirus infections--current and prospective therapies.
Stanley M
J Natl Cancer Inst Monogr; 2003; (31):117-24. PubMed ID: 12807955
[TBL] [Abstract][Full Text] [Related]
3. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.
Corona Gutierrez CM; Tinoco A; Navarro T; Contreras ML; Cortes RR; Calzado P; Reyes L; Posternak R; Morosoli G; Verde ML; Rosales R
Hum Gene Ther; 2004 May; 15(5):421-31. PubMed ID: 15144573
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary study on the relationship between loads of human papillomavirus in cervical carcinoma and cervical intraepithelial neoplasia].
Li SM; Zhang WH; Wu LY; Zhao FH; Huang MN; Li N; Chen F
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):400-2. PubMed ID: 15312325
[TBL] [Abstract][Full Text] [Related]
6. Management of low-grade CIN: follow-up or treatment?
Hording U; Junge J; Rygaard C; Lundvall F
Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):49-52. PubMed ID: 7493708
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of adenoassociated virus 2 and human papilloma virus 16 and 18 infection in cervical cancer biopsies.
Ahn WS; Bae SM; Chung JE; Lee HK; Kim BK; Lee JM; Namkoong SE; Kim CK; Sin J
Gynecol Oncol; 2003 Apr; 89(1):105-11. PubMed ID: 12694662
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions.
Chan PK; Li WH; Chan MY; Ma WL; Cheung JL; Cheng AF
J Med Virol; 1999 Oct; 59(2):232-8. PubMed ID: 10459162
[TBL] [Abstract][Full Text] [Related]
9. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
Nagai Y; Maehama T; Asato T; Kanazawa K
Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the possible protective role of adeno-associated virus type 2 infection in HPV-associated premalignant disease of the cervix.
Odunsi KO; van Ee CC; Ganesan TS; Shelling AN
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):342-5. PubMed ID: 10985891
[TBL] [Abstract][Full Text] [Related]
11. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
Snoeck R; Noel JC; Muller C; De Clercq E; Bossens M
J Med Virol; 2000 Feb; 60(2):205-9. PubMed ID: 10596022
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.
Grabosch SM; Shariff OM; Helm CW
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004121. PubMed ID: 29431861
[TBL] [Abstract][Full Text] [Related]
13. Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions.
Bello BD; Spinillo A; Alberizzi P; Cesari S; Gardella B; D'Ambrosio G; Roccio M; Silini EM
J Med Virol; 2009 Apr; 81(4):703-12. PubMed ID: 19235847
[TBL] [Abstract][Full Text] [Related]
14. Retinoids for preventing the progression of cervical intra-epithelial neoplasia.
Helm CW; Lorenz DJ; Meyer NJ; Rising WW; Wulff JL
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD003296. PubMed ID: 23740788
[TBL] [Abstract][Full Text] [Related]
15. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia.
Del Priore G; Gudipudi DK; Montemarano N; Restivo AM; Malanowska-Stega J; Arslan AA
Gynecol Oncol; 2010 Mar; 116(3):464-7. PubMed ID: 19939441
[TBL] [Abstract][Full Text] [Related]
16. Detection and typing of human papillomavirus in cervical intraepithelial neoplasia grade III in Thai women.
Lertworapreecha M; Bhattarakosol P; Niruthisard S
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):507-11. PubMed ID: 10437947
[TBL] [Abstract][Full Text] [Related]
17. [The correlation of a positive DNA HPV HR test and genotyping human papilloma viruses with the presence of CIN, in women with cytologic evidence of ASC-US and LSIL].
Bedziński M; Józefiak A; Szczepańska M; Pruski D; Kedzia W; Spaczyński M
Ginekol Pol; 2008 Jul; 79(7):490-3. PubMed ID: 18819456
[TBL] [Abstract][Full Text] [Related]
18. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN).
Acladious NN; Sutton C; Mandal D; Hopkins R; Zaklama M; Kitchener H
Int J Cancer; 2002 Mar; 98(3):435-9. PubMed ID: 11920596
[TBL] [Abstract][Full Text] [Related]
19. bcl-2 immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia.
Cooper K; Haffajee Z; Taylor L
Mod Pathol; 1999 Jun; 12(6):612-7. PubMed ID: 10392638
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions.
Skyldberg B; Fujioka K; Hellström AC; Sylvén L; Moberger B; Auer G
Mod Pathol; 2001 Apr; 14(4):279-84. PubMed ID: 11301343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
